Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Papular filariasis].

E Mahé1, M F Torchet, C Chrétiennot

  • 1Service de dermatologie, hôpital Necker-Enfants malades, 149, rue de Sèvres, 75015 Paris, France. emmanuel.mahe@bch.ap-hop-paris.fr

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|July 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics and outcomes of patients with pediatric-onset non-mastocytosis mast cell activation disorders: A CEREMAST study.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Pseudoxanthoma elasticum - The skin as a sentinel of systemic disease.

Annales de dermatologie et de venereologie·2026
Same author

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Therapeutic patient education through digital technology: Recommendations for paediatrics and dermatology.

Annales de dermatologie et de venereologie·2026
Same author

Risk of persistent hypogammaglobulinaemia in children with autoimmune bullous dermatoses treated with rituximab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Autoimmune bullous dermatosis in children: French guidelines.

Annales de dermatologie et de venereologie·2025
Same journal

Family experiences of paediatric palliative care during hospital-at-home: a systematic review.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Knowledge of maternity caregivers on vaccination BCG recommendations and circuits.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

"CRANIOQUALITY study: Quality of life in children with non-syndromic craniosynostosis after surgery".

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Chronological evolution of brain imaging of hemiconvulsion-hemiplegia-epilepsy from 5 cases in Mayotte island.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Point-of-care capillary blood ketone testing to predict the need for intravenous or nasogastric tube rehydration in children with acute gastroenteritis.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Transition practices of patients with inflammatory bowel disease from pediatric to adult healthcare systems. Results from a national survey.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
See all related articles

Onchocerciasis, or river blindness, can cause skin issues like pruritus. A Cameroonian child

Area of Science:

  • Tropical medicine
  • Dermatology
  • Parasitology

Background:

  • Onchocerciasis, commonly known as river blindness, is a significant public health concern in endemic regions.
  • Imported cases of cutaneous or ocular onchocerciasis are infrequent in non-endemic countries like France.

Observation:

  • A case of chronic papular onchodermatitis with significant lymphadenopathy was observed in a child from Cameroon.
  • The patient presented with intense pruritus, a key symptom of cutaneous onchocerciasis.

Findings:

  • Treatment with a single dose of ivermectin led to the resolution of the child's dermatological symptoms and lymphadenopathy.
  • Ivermectin is effective against microfilariae but requires repeated administration to eliminate adult worms and prevent relapses.

Related Experiment Videos

Implications:

  • Physicians should consider onchocerciasis in patients presenting with pruritus and originating from endemic areas.
  • Cutaneous manifestations of onchocerciasis are diverse and influenced by exposure duration and host immune response.
  • While ivermectin is the current standard treatment, its limitations necessitate ongoing management strategies for persistent adult worm infections.